Favism

Download PDF

Recent Publications on Favism:
[Case of laparoscopic cholecystectomy in a patient with glucose-6-dehydrogenase deficiency] We report management of anesthesia in a patient suffering from...	9th April, 2008	Department of Anesthesiology, St. Marianna University School of Medicine,	Masui. 2008 Feb;57(2):200-2.
Cost-benefit analysis of G6PD screening in Lebanese newborn males. INTRODUCTION: G6PD deficiency is one of the most prevalent genetic...	7th December, 2007	Newborn Screening Laboratory, Medical Genetic Unit, Faculty of Medicine,	J Med Liban. 2007 Jul-Sep;55(3):129-32.
Glucose-6-phosphate dehydrogenase--from oxidative stress to cellular functions and degenerative diseases. Glucose-6-phosphate dehydrogenase (G6PD), the first and rate-limiting...	14th November, 2007	Graduate Institute of Medical Biotechnology and Department of Medical	Redox Rep. 2007;12(3):109-18. DOI Direct Link
A comprehensive study on the major mutations in glucose-6-phosphate dehydrogenase-deficient polymorphic variants identified in the coastal provinces of Caspian Sea in the north of Iran. BACKGROUND: The aim of this study was the molecular analysis of G6PD...	24th July, 2007	Department of Medical Genetics, Faculty of Medicine, Tehran University of	Clin Biochem. 2007 Jun;40(9-10):699-704. Epub 2007 Apr 6. DOI Direct Link
Molecular basis of glutathione reductase deficiency in human blood cells. Hereditary glutathione reductase (GR) deficiency was found in only 2 cases...	24th May, 2007	Sanquin Research and Landsteiner Laboratory, Academic Medical Centre,	Blood. 2007 Apr 15;109(8):3560-6. Epub 2006 Dec 21. DOI Direct Link
→View more research publications.

Favism Clinical Trials:
A Test to Predict the Hemolytic Potential of Drugs in G6PD Deficiency	Glucosephosphate Dehydrogenase Deficiency;   Favism

Favism Patents:
US Patent No.	Title
7375133	Pharmaceutical compositions including carotenoid ether analogs or derivatives for the inhibition and amelioration of disease
6358697	Intracellular pharmaceutical targeting
6313169	Lutein esters having high bioavailability
6313164	Dithiolin derivatives, their preparation and their therapeutic effect
6245566	Human embryonic germ cell line and methods of use
→View more patents.

BioPortfolio Ltd. offers e-mail and postal lists for Favism scientists - we have details of around 59 individuals working on Favism .

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.  See User Agreement

Send comments and feedback to:
Peter Barfoot Managing Director, BioPortfolio Ltd.
UK Tel: (+44) 1300 321501
USA Voicemail and Fax: (+1) 415 680 2472

All rights reserved. All other trademarks recognized.

BioPortfolio Limited is registered in England & Wales at Wessex Barn, Dorchester Road, Frampton, Dorset, DT2 9NB, UK. No.3312883 VAT No. GB 744 6483 10

Copyright 1997-2008 - BioPortfolio Limited.